COVID-19 Study – Ambulatory Adult Patients with Symptomatic COVID-19

Medical Condition: COVID-19

Facility/Clinic: Avacare Clinical Research at Wilmington Health

Age: 18 and older

Gender: Males and Females

Description: A Randomized, double-blind, placebo-controlled, multicenter study of Ensovibep (MP0420) in ambulatory adult patients with symptomatic COVID-19

Enrollment: Open

Duration: approximately 3 months

Number of visits in study: 9 Patient

Compensation: $83.00 per completed study visit

The team at WH Research can guide interested clinical research participants through the process of enrolling in a trial.
Please call 910-799-5500 between the hours of 8am-5pm for general research questions.